Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	6 Months Ended
Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Statement [Abstract]
Net sales	$ 54,564	$ 39,031	$ 104,687	$ 78,524
Cost of products sold	45,863	35,434	89,790	69,253
Gross profit	8,701	3,597	14,897	9,271
Operating expenses	7,946	6,487	14,538	13,252
Operating profit (loss)	755	(2,890)	359	(3,981)
Pension (expense) income	(8)	89	(35)	178
Other income, net	79	46	546	98
Interest expense	(370)	(132)	(754)	(238)
Profit (Loss) before income taxes	456	(2,887)	116	(3,943)
Income tax expense	570	195	949	446
Net loss	(114)	(3,082)	(833)	(4,389)
Less: Net earnings attributable to the non-controlling interest	129	18	157	56
Net loss attributable to Kewaunee Scientific Corporation	$ (243)	$ (3,100)	$ (990)	$ (4,445)
Net loss per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in dollars per share)	$ (0.09)	$ (1.11)	$ (0.35)	$ (1.60)
Diluted (in dollars per share)	$ (0.09)	$ (1.11)	$ (0.35)	$ (1.60)
Weighted average number of common shares outstanding
Basic (in shares)	2,830	2,789	2,819	2,783
Diluted (in shares)	2,830	2,789	2,819	2,783

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227